在MDA-MB-231细胞系上,4-基-2-甲基佐醇的抗瘤和亡潜力
Misbah Majeed1, Tahir Maqbool1, Tayyeba Majeed1
1Institute of Molecular Biology and Biotechnology/Center for Research in Molecular Medicine, The University of Lahore, Lahore, Pakistan.
Asian Pacific journal of cancer prevention : APJCP
|December 29, 2025
概括
4-基-2-甲基西醇显著降低了乳腺癌细胞活力,并在MDA-MB-231细胞中促进了细胞死亡. 这种化合物还降低了血管新生和增加了细胞亡,表明其作为乳腺癌治疗剂的潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 乳腺癌是女性癌症相关死亡的主要原因.
- MDA-MB-231细胞系是研究乳腺癌的关键模型.
- 4-氧-2-甲基佐醇表现出潜在的抗氧化剂,抗增殖和亲亡性质.
研究的目的:
- 评估4-基-2-甲基西醇对MDA-MB-231乳腺癌细胞的亡性,抗增殖性和抗氧化作用.
- 为了确定4-基-2-甲基佐醇治疗效果的最佳剂量.
主要方法:
- 细胞活力通过MTT,水晶紫色和试蓝色试验进行评估.
- 用ELISA测量的血管新生和亡标志物 (VEGF,p53).
- 抗氧化剂水平 (GSH,SOD) 的量化.
- 通过划痕试验和DAPI/PI染色证实了亡.
主要成果:
- 一剂50μg/ml的4-基-2-甲基西醇显著降低了MDA-MB-231细胞活力和诱导细胞死亡.
- 该化合物降低了血管生成潜力 (VEGF水平) 并增加了p53水平.
- 抗氧化剂水平 (SOD,GSH) 降低,并证实了亡.
结论:
- 4-基-2-甲基西醇对MDA-MB-231乳腺癌细胞表现出显著的抗增殖和亡作用.
- 这些发现表明4-基-2-甲基索醇是乳腺癌治疗的潜在治疗候选者.
相关概念视频
Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


